GSK3335103
GSK3335103 is an orally active, non-peptide αvβ6 integrin inhibitor (pIC50=8) . GSK3335103 can be used in the study of pulmonary fibrosis[1].
Product Specifications
CAS Number
1893340-21-0
UNSPSC
12352005
Target
Integrin
Type
Reference compound
Related Pathways
Cytoskeleton
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/gsk3335103.html
Smiles
O=C(O)C[C@@H](C1=CC=CC(OCCOC)=C1)CN2C[C@@](CCC3=NC4=C(CCCN4)C=C3)(F)CC2
Molecular Formula
C27H36FN3O4
Molecular Weight
485.59
References & Citations
[1]Procopiou P A, et al. Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic αvβ6 Integrin Inhibitors[J]. Journal of Medicinal Chemistry, 2024.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY400453 100 µg
AdSS 2 (ADSS) (NM_001126) Human Over-expression Lysate
Sign In for Pricing
View Details 
TRC-D485905-500MG 500 mg
(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetic Acid
Sign In for Pricing
View Details 
BNC680856-500 1x 500 µL
WT1 (Wilm's Tumor 1) (6F-H2), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details